The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity
Authors:
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 88 (3) , 256-263
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Napsin A (TA02) is a useful alternative to thyroid transcription factor‐1 (TTF‐1) for the identification of pulmonary adenocarcinoma cells in pleural effusionsDiagnostic Cytopathology, 2007
- Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary BladderClinical Cancer Research, 2005
- Processing of Pulmonary Surfactant Protein B by Napsin and Cathepsin HJournal of Biological Chemistry, 2004
- Involvement of Napsin A in the C- and N-terminal Processing of Surfactant Protein B in Type-II Pneumocytes of the Human LungJournal of Biological Chemistry, 2003
- Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinomaBritish Journal of Cancer, 2003
- A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cellsOncogene, 2001
- Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancerBritish Journal of Cancer, 1999
- Napsins: new human aspartic proteinasesFEBS Letters, 1998
- Molecular cloning of a novel mouse aspartic protease‐like protein that is expressed abundantly in the kidneyFEBS Letters, 1997
- Clinical significance of cathepsin D in primary ovarian cancerEuropean Journal of Cancer, 1994